Status:
COMPLETED
Assessment of Positron Emission Tomography to Early Detect Frailty in Onco-geriatry
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Patients Over 75 Years Old With a Cancer Discovery
Eligibility:
All Genders
75+ years
Phase:
NA
Brief Summary
Oncogeriatric frailty assessment is a multifactorial approach to determine the most appropriate treatment for the health status of elderly cancer patients and this assessment is recommended for patien...
Eligibility Criteria
Inclusion
- patients who are more than 75 years old with written informed consent
- patients referred for 18F-FDG PET in an oncological disease newly diagnosed
- patients insured under social security
Exclusion
- patients with disease in final stage and life expectancy less than 6 months
- patients under guardianship or curators
- patients with abnormal neurological tests: MMS\< 27, with neoplastic or other brain lesions or showing ischemic or cerebral stroke damage
- confused or agitated patient unable to realize a PET
- radiotherapy ou chemiotherapy one year at least of the patient enrollment
Key Trial Info
Start Date :
October 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 10 2022
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT03370809
Start Date
October 1 2018
End Date
August 10 2022
Last Update
August 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU NANCY Brabois, nuclear medicine department
Vandœuvre-lès-Nancy, France, 54511